Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · April 21, 2022

MR-proANP as a Potential Biomarker of Atrial Fibrillation in Patients With Ischemic Stroke

Journal of the American College of Cardiology


Additional Info

Journal of the American College of Cardiology
Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemic Stroke
J Am Coll Cardiol 2022 Apr 12;79(14)1369-1381, J Schweizer, M Arnold, IR König, A Bicvic, LP Westphal, V Schütz, C Inauen, N Scherrer, A Luft, M Galovic, C Ferreira Atuesta, T Pokorny, M Arnold, U Fischer, LH Bonati, GM De Marchis, T Kahles, K Nedeltchev, CW Cereda, G Kägi, A Bustamante, J Montaner, G Ntaios, D Sagris, C Foerch, K Spanaus, A von Eckardstein, M Katan

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading